Why is condensing information a critical skill for a CEO?
How do you keep dozens of people across different functions of a company feel like one team?
And why should you keep patients and caregivers at the centre of drug discovery?
Today I’m joined by Susan Hill, CEO of Mestag Therapeutics, a Cambridge-based company developing new programs for cancer and inflammatory disease.
We’ll touch on the science towards the end of the episode.
About LifeScience ORG
It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.
The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.
Chapters
0:00 – From Lab to Boardroom
6:23 – The Call to Lead
10:26 – Knowing When to Jump
14:12 – Comfortable with Uncertainty
16:33 – Shared Challenges at the Top
21:01 – The Art of Condensing
27:56 – Tackling Solid Tumors
32:46 – Multiple Teams, One Mission
34:36 – Closing the Gap for Patients
39:00 – Sailing Toward the Horizon
